Sherman v. Medicine Shoppe International, Inc.

581 F. Supp. 445, 1984 U.S. Dist. LEXIS 19187
CourtDistrict Court, E.D. Pennsylvania
DecidedFebruary 24, 1984
Docket79-1351, 83-1965
StatusPublished
Cited by5 cases

This text of 581 F. Supp. 445 (Sherman v. Medicine Shoppe International, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sherman v. Medicine Shoppe International, Inc., 581 F. Supp. 445, 1984 U.S. Dist. LEXIS 19187 (E.D. Pa. 1984).

Opinion

MEMORANDUM AND ORDER

TROUTMAN, Senior District Judge.

This matter is before the Court on Medicine Shoppe International, Inc.’s (“MSI”), Second Motion to Reopen and Enforce Settlement Agreement, and for Summary Judgment in Accordance with Settlement, and the Motion Requesting Equitable Recision of a Portion of Settlement Agreement filed by plaintiff in Cause No. 79-1351 and all defendants in Cause No. 83-1965 (such parties hereinafter being referred to collectively as “Sherman”). For the reasons set forth below, MSI’s motion will be granted, and Sherman’s motion will be denied. Because of the complexity of the situation, the facts and legal positions of the parties have been analyzed at some length.

I.

THE FIRST SETTLEMENT

In 1979, William P. Sherman filed Civil Action 79-1351 in the state courts of Pennsylvania. The case was subsequently removed to this Court and a counterclaim was filed by MSI. Sherman alleged, inter alia, various breaches of two license agreements between himself and MSI, pursuant to which MSI licensed Sherman to utilize MSI’s trademark, tradename and methods of doing business in the operation of two apothecary-type pharmacies (one in Reading, the other in Lancaster). MSI, in its counterclaim in Civil Action 79-1351 and its complaint in Civil Action No. 83-1965, sought enforcement of those license agreements and, in particular, the termination provisions contained in them.

Civil Action No. 79-1351 was called for trial on the morning of June 21, 1983. Pri- or to the case actually commencing, the parties reached a settlement (the “First Settlement”) resolving all issues in both cases. The First Settlement was reached after lengthy negotiations, at which all parties were represented by counsel. Its terms were read to the Court, but the Court’s reporter was not in attendance. Despite several attempts by MSI to make a formal record of the agreement, that was impossible. In any event, all parties agreed that the essence of the first settlement was the payment of $110,000 by Sherman to MSI, and MSI’s purchase of a pharmacy in Reading, PA, (the “Pharmacy”) from Sherman, generally along the lines called for in the termination provisions of the License Agreements.

On June 23, 1983, MSI’s counsel (“Rovak”) sent a letter (the “Letter”) setting out the terms of the First Settlement to William Atlee, Jr., counsel for Sherman. The Letter correctly recorded the terms of the First Settlement, including a proviso that although the parties intended to execute a formal agreement, the First Settlement was a full settlement agreement in and of itself.

On June 24, 1983, Atlee wrote Rovak, and although raising a procedural point, stated that the Letter “sets forth most of the essential terms” pertaining to the First Settlement. Rovak called Atlee to discuss the procedural point raised by Atlee, at which time Atlee confirmed that there were no essential terms of the First Settlement not accurately set out in the Letter. Rovak next sent Atlee an agreement, and related documents which were intended to be formalized documentation of the First Settlement (the “Rovak Agreement”). These documents did not vary any essential term *447 of the agreement, and merely contained standard wording, so-called “boilerplate”, of a contract to sell a small business.

On August 9,1983, an attorney in Atlee’s firm notified Rovak that the Rovak Agreement had not been yet reviewed. Rovak became concerned and wrote Atlee stating that while changes in formal wording were of no consequence to MSI, MSI would not accept any substantive renegotiation of the First Settlement. Nonetheless, on August 26, 1983, Atlee sent a revised set of settlement documents to Rovak. Those documents were materially different from the First Settlement of June 21, 1983. Upon their receipt, Rovak contacted Atlee and again told him that while MSI would stand by the terms of the First Settlement it was not concerned about formal wording, and would even accept Atlee’s version if the substantive terms conformed to the First Settlement.

In the meantime, MSI had relied upon the First Settlement by contracting to sell the Pharmacy to a Mr. Naglak, under a new license agreement.

However, Sherman refused to conclude the First Settlement. When MSI sought to enforce that settlement, Sherman responded by pointing out differences between the Rovak Agreement and the version sent by Atlee, as proof that no binding agreement had ever been reached. The recitation was irrelevant, for the issue before the Court was not whether or not the documents sent by Rovak or Atlee signified an inability to reach an agreement, but whether the First Settlement was in and of itself binding upon the parties. This Court spent the 29th and 30th of September, 1983 hearing testimony on MSI’s first motion, and Sherman’s response, during which time Rovak, Atlee, William Sherman, and Ronald T. Hofmeister, an executive of MSI, all testified as to the terms of the First Settlement. After the evidence had been closed, but before the Court reached any decision, the parties announced that they had once again reached a settlement. It is this second settlement that MSI seeks to enforce, and which Sherman seeks to partially rescind.

II.

THE SECOND SETTLEMENT

The First Settlement contained inter alia, a provision whereby Sherman would lease the real estate upon which the Pharmacy sits to MSI. At the hearing of the 29th and 30th of September, it was obvious that most of Sherman’s unhappiness over the First Settlement revolved around the fact that the lease called for in that agreement was unsatisfactory both to William T. Sherman and a business associate, Mr. Thomas Frontz. In particular, Mr. Sherman felt that the terms of the lease described in the First Settlement were such as to make a subsequent sale of the real estate difficult. Mr. Sherman also thought that under the First Settlement, the leasing of the property in question could be accomplished on the terms called for in the lease between Royer Pharmacy, Inc. (a corporation controlled by Sherman) and Madeline Lipman, pursuant to which Royer Pharmacy, Inc. leased certain property from Madeline Lipman beginning in 1974 (the “Lip-man Lease”). Sherman also objected to other terms in the First Settlement.

Late on September 30th, Atlee approached Rovak and asked if MSI would agree to alter the First Settlement in accordance with Sherman’s wishes, which At-lee listed, and if so, what the cost to Sherman would be. Atlee and Rovak then negotiated over this cost, and over changes Sherman wanted to make in the First Settlement. As a way to structure the proposed settlement, Atlee began by utilizing still another form of agreement. This one was a document he had sent to Rovak in an effort to settle the matters raised in MSI’s first motion. This form had been prepared by Dennis Ward, another attorney for Sherman and has been referred to as the “Ward Agreement”.

Rovak refused to use the Ward Agreement, insisting instead upon the use of the Rovak Agreement. Atlee then agreed to utilize the Rovak Agreement, but wanted to incorporate certain terms of the Ward *448 Agreement into the Rovak Agreement, and make other changes as well. A number of provisions of the Ward Agreement were in fact incorporated into the Rovak Agreement, and in most cases the incorporation was verbatim.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ballato v. General Electric
147 F.R.D. 95 (E.D. Pennsylvania, 1993)
BHP Petroleum Co., Inc. v. Okie
836 P.2d 873 (Wyoming Supreme Court, 1992)
Keenheel v. Commonwealth, Pennsylvania Securities Commission
579 A.2d 1358 (Commonwealth Court of Pennsylvania, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
581 F. Supp. 445, 1984 U.S. Dist. LEXIS 19187, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sherman-v-medicine-shoppe-international-inc-paed-1984.